You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 19, 2024

DESFERAL Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Desferal, and what generic alternatives are available?

Desferal is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in DESFERAL is deferoxamine mesylate. There are seven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the deferoxamine mesylate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desferal

A generic version of DESFERAL was approved as deferoxamine mesylate by HOSPIRA on March 17th, 2004.

  Try a Trial

Drug patent expirations by year for DESFERAL
Drug Prices for DESFERAL

See drug prices for DESFERAL

Recent Clinical Trials for DESFERAL

Identify potential brand extensions & 505(b)(2) entrants

Michigan Medicine PKUHSC Joint Institute for Translational & Clinical ResearchPhase 2
Aditya S. Pandey, MDPhase 2
Eshmoun Clinical Research CentrePhase 3

See all DESFERAL clinical trials

Pharmacology for DESFERAL
Drug ClassIron Chelator
Mechanism of ActionIron Chelating Activity
Anatomical Therapeutic Chemical (ATC) Classes for DESFERAL

US Patents and Regulatory Information for DESFERAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis DESFERAL deferoxamine mesylate INJECTABLE;INJECTION 016267-002 May 25, 2000 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Novartis DESFERAL deferoxamine mesylate INJECTABLE;INJECTION 016267-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.